In the Spotlight
From Neighbors to Partners: How We Plan to Help Children Through Iniuva
A chance encounter in a Hamburg apartment building brought Markus Baumanns and pediatrician Professor Søren Gersting together. Today, they are building Iniuva together—a startup that uses artificial intelligence to develop drugs for rare genetic diseases in children. Company Companions is on board as an investment partner: Markus Baumanns will serve as chairman of the board and, together with Gersting, is establishing the governance and financing structure for the next phase of growth. “ZEIT für Unternehmer” met with the two for an interview.
Monthly Newsletter
"Embrace Uncertainty"
Do you have responsibility in a medium-sized company, a fast-growing start-up or a large non-profit organization?
In his monthly newsletter, Dr. Markus Baumanns shares industry insights, discusses business news, and poses thought-provoking questions. Look forward to food for thought, new perspectives, and stimulating discussions—sign up for the newsletter now!